ALLENEUTRAL

Revenue Growth (YoY)

9.7%

Higher than 61% of Industrials sector peers

Updated 1927h ago

Sector Performance

61th percentile

ALLE

9.7%

Sector Median

7.0%

Sector Avg

4.4%

📊

Deep Analysis

Allegion’s current revenue growth of 9.7% year-over-year (YoY) measures how much the company’s sales increased compared to the same period one year ago.

This rate is above the Industrials sector median of 7.3%, placing Allegion in the 57th percentile of its peer group. The trend data for this metric is not available — both the YoY change from the prior period and the quarter-over-quarter (QoQ) change are listed as N/A, so no direction can be inferred. Because the growth rate is above the median but not at the top of the sector, the level alone suggests modest competitive advantage, but the lack of trend information creates uncertainty about whether performance is improving or slowing. This combination of a decent but unexceptional current level and no observable trend points to a balanced risk-opportunity profile. Therefore, the 9.7% revenue growth neither strongly supports nor contradicts the overall NEUTRAL verdict on Allegion.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about ALLE?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does ALLE's Revenue Growth (YoY) compare to its sector?

ALLE's Revenue Growth (YoY) of 9.7% compares to a Industrials sector median of 7.0%, placing it in the 61th percentile.

Who are ALLE's closest peers by Revenue Growth (YoY)?

The closest Industrials peers by Revenue Growth (YoY) include: ADP (7.0%), AVY (7.0%), RTX (8.7%), ALK (5.2%), GXO (10.8%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.